MetaOptima Technology

Vancouver, BC, Canada  All Canada companies → — Founded 2012
Imaging AI Specialist Specialty-Focused AI
Dermatology
Clinical Decision Support & Reference Practice Management & Scheduling
Series A — $9.1M
Website Claim this company

Products

DermEngine
MetaOptima Technology Inc.
Clinical Decision Support & Reference
DermEngine is an intelligent dermatology software platform by MetaOptima Technology Inc. for imaging, documentation, and AI-powered analysis of skin conditions, streamlining workflows for dermatologists.
Subscription-based, starting from $29 per user/month.

See all 1 product →

About MetaOptima Technology

MetaOptima Technology, founded in 2012, is a leading digital health company specializing in AI-driven solutions for dermatology. Headquartered in Vancouver, Canada, with additional offices in Sydney, Australia, and Boston, USA, the company is dedicated to enhancing the accessibility and effectiveness of high-quality dermatological care through advanced cloud and mobile-based technologies.

The company’s flagship product, DermEngine, is an intelligent dermatology software platform designed for comprehensive imaging, analysis, and documentation of various skin conditions. It integrates seamlessly with existing Electronic Medical Record (EMR) and Electronic Health Record (EHR) systems, including Epic, Cerner, and Modernizing Medicine, to streamline clinical workflows and improve communication among healthcare providers. Complementing DermEngine is MoleScope, a smartphone-attachable dermatoscope that enables patients and professionals to capture high-quality images of moles for tracking and early detection.

MetaOptima’s latest innovation, DermEngine AI, leverages a proprietary database of over 2.7 million patient records and 10 million images to provide AI-powered clinical decision support for the early identification of skin cancer. This technology aims to reduce the rate of unnecessary biopsies, improve diagnostic accuracy, and ultimately lead to better patient outcomes and more efficient care coordination in both in-clinic and teledermatology settings.

Focus Areas

Dermatology Skin Cancer Detection Artificial Intelligence Digital Health Intelligent Dermoscopy Skin Imaging Analytics Teledermatology EMR/EHR Integration Mobile Health

Business Intelligence

Key InvestorsSkip Capital, AirTree Ventures, Nimbus Synergies, National Research Council Canada, Canadian Space Agency
PartnershipsSonic Healthcare, Digital Health & Discovery Platform (DHDP), Circle Innovation, Telus, Change Healthcare, CareTeam, University of Victoria
TechnologyCloud-native, AI-driven (deep-learning algorithms, content-based image retrieval), Mobile App (iOS/Android), EMR/EHR integration, 3D Total Body Photography

What Physicians Need to Know

AI-Powered Skin Cancer Detection & Analysis
DermEngine leverages award-winning artificial intelligence (AI) algorithms for intelligent analysis of skin conditions, including skin cancer. Features like Visual Search compare dermoscopic images against a vast database of pathology-labeled lesions to provide clinical decision support, risk of malignancy, and top diagnoses.
Advanced Digital Dermoscopy & Skin Imaging
The platform offers sophisticated tools for imaging, documentation, and analysis of skin, hair, and nails. This includes seamless integration with MoleScope mobile dermatoscopes and the innovative OptimaScan for AI-assisted 3D Total Body Photography, capable of capturing high-quality 3D scans in under a minute.
Comprehensive Patient & Lesion Tracking
DermEngine provides smart features like 3D Body Mapping, Lesion Mapping, and Lesion Matching to automatically identify, map, and track changes in lesions over time. The Evolution Tracker allows for side-by-side comparison of images to monitor healing or detect subtle changes, prioritizing high-risk spots.
Teledermatology & Remote Care Capabilities
As a cloud-based solution, DermEngine facilitates accessible teledermatology services, enabling store-and-forward consultations and real-time communication between healthcare providers and patients. This helps reduce wait times and extends care to a wider patient base.
Streamlined Workflow & Practice Efficiency
The platform is designed to optimize clinical workflows by automating time-consuming tasks. Features like Smart Snap auto-assign images to existing spots, Digital Hair Removal enhances image clarity, and automated documentation reduces administrative burden, allowing physicians to focus more on patient care.
Cross-Platform Accessibility & Secure Cloud Storage
DermEngine is a HIPAA-compliant, cloud-based platform accessible from any device (desktop, laptop, tablet, smartphone) across iOS, Android, web, Mac, and Apple TV. Data is securely stored in the cloud, ensuring accessibility anytime, anywhere, with automatic syncing and backups.
Physician Tip

For physicians, MetaOptima's DermEngine stands out by significantly enhancing diagnostic accuracy and efficiency in dermatology. The AI-powered clinical decision support tools, particularly Visual Search, offer evidence-based insights to aid in early skin cancer detection. The advanced 3D Total Body Photography with OptimaScan and intelligent lesion tracking features (Lesion Mapping, Lesion Matching) provide a comprehensive and efficient way to monitor patients over time, reducing the need for manual comparisons. The platform's teledermatology capabilities and seamless EMR/EHR integration streamline patient management and communication, ultimately freeing up valuable physician time from administrative tasks to focus on delivering high-quality patient care. Its cross-platform accessibility ensures that critical patient data and analytical tools are always at your fingertips, whether in the clinic or on the go.

DermEngine offers simplified integration services with existing EMR/EHR and practice management systems (PMS) to provide a seamless experience. It is a cloud-based solution that stores EMR/EHR data in an easily accessible system without requiring internal servers or complex network configurations. They provide integration with popular EMR systems like Cerner and Epic, and can also work to integrate with other systems upon request, ensuring data synchronization and interoperability.

Products by MetaOptima Technology

1 product in the directory

DermEngine
MetaOptima Technology Inc.
Clinical Decision Support & Reference
DermEngine is an intelligent dermatology software platform by MetaOptima Technology Inc. for imaging, documentation, and AI-powered analysis of skin conditions, streamlining workflows for dermatologists.
Subscription-based, starting from $29 per user/month.

What the Web Says

MetaOptima Technology, particularly known for its DermEngine software, generally receives positive reviews for its innovative AI-powered dermatology solutions. The platform is praised for streamlining workflows, enhancing diagnostic capabilities, and facilitating remote consultations. While product reviews are largely favorable, detailed company/employer reviews are less prevalent across major platforms, with some general 'Optima' or 'Dermatology' company reviews indicating mixed sentiments about work-life balance and management.

Overall: Positive

Strengths

  • AI-powered for enhanced diagnostic capabilities and clinical decision support.
  • Streamlines workflows for imaging, documentation, and assessment of skin conditions.
  • Supports telemedicine and remote consultations, improving access to care.
  • Offers high-resolution image analysis, sometimes surpassing traditional dermoscopes.
  • Secure encryption for patient information is a paramount feature.
  • Scalable and cost-effective with flexible pricing, suitable for various clinic sizes.

Limitations

  • Limited detailed company/employer reviews specifically for MetaOptima Technology.
  • Potential for AI bias in algorithms leading to misdiagnosis for certain skin tones.
  • Digital divide may limit access for low-income and older populations.
  • Regulatory hurdles and differing state laws can complicate interstate practice.
  • Data security and privacy concerns persist with increased remote consultations.
  • Lack of physical touch can hinder accurate diagnosis in complex cases.

Based on reviews from: A Professional Review of DermEngine & MoleScope, DermEngine Software Reviews, Demo & Pricing - 2026, DermEngine Reviews - 2026 - Slashdot, DermEngine Reviews in 2026 - SourceForge, DermEngine Software Pricing, Alternatives & More 2026 | Capterra, DermEngine: The AI Technology Revolutionising Dermatology - HotDoc for Practice, Find best 15 DermEngine Alternatives - Capterra Canada 2026, Top 10 DermEngine Alternatives & Competitors in 2026 - G2, Page 2 | Best Dermatology Software 2026 | Capterra, MetaOptima Careers and Employment | Indeed.com, Ratings & Reviews - DermEngine - App Store - Apple, DermEngine 2026: Honest Expert Review - ITQlick, DermEngine 2026 Pricing, Features, Reviews & Alternatives | GetApp, Surrey RCMP signs up for anti-skin cancer technology | Vancouver Sun

Last updated: 2026-07-22

Videos

News, demos, and interviews about MetaOptima Technology.

Loading videos...

Videos load interactively. If none appear, search YouTube for MetaOptima Technology →

View all on YouTube

Press & Coverage

DermEngine Blog
MetaOptima Joins the Digital Health & Discovery Platform (DHDP)
MetaOptima has joined Canada's Digital Health & Discovery Platform (DHDP) to collaborate on developing and adopting responsible digital health technologies that improve outcomes for patients, providers, and healthcare systems across Canada. The company's secure cloud-based platform, DermEngine, allows clinicians to track changes over time, compare images, and identify new or evolving lesions with greater accuracy.
2026-01
GlobeNewswire
Artificial Intelligence Powered Dermatology Lesion Triaging Research Report 2025: Market to Reach $3.4 Billion by 2029, Driven by Proscia Inc., SkinVision B.V., and MetaOptima Technology
A research report predicts the AI-powered dermatology lesion triaging market will reach $3.4 billion by 2029, with MetaOptima Technology identified as a key driver. The market's growth is attributed to increasing skin cancer prevalence, advancements in diagnostic technology, and the rising use of telemedicine.
2025-11
DermEngine Blog
Healing with Technology: OptimaScan + DermEngine
MetaOptima's OptimaScan, a patent-pending intelligent imaging station, has received support from the INOVAIT Pilot Fund to advance 3D body mapping and enhance DermEngine's AI-powered dermatology and skin disease management. OptimaScan integrates with DermEngine's Total Body Photography module to provide AI-powered image-guided photography for rapid, standardized, and data-driven documentation.
2025-09
DermEngine Blog
British Columbia receives $4.7M in funding for Healthtech SMEs, including MetaOptima
MetaOptima was among 35 companies to receive funding from the new Healthtech SME Program by PacifiCan and Circle Innovation in British Columbia, Canada. This funding supports the development and commercialization of health technologies, with MetaOptima showcasing its MoleScope mobile dermatoscope and DermEngine intelligent dermatology platform.
2023-12
News-Medical.Net
Mobile AI rivals specialists in diagnosing skin cancer, outperforms junior doctors
A clinical trial published in Lancet Digital Health found that mobile phone-powered AI technology, utilizing MetaOptima Technology's DermEngine software, was accurate for diagnosing suspicious pigmented skin cancer, performing equivalently to specialists and superior to novices. The study highlighted the potential of affordable mobile technology in skin cancer diagnosis.
2023-09
Nimbus Synergies
Nimbus Synergies Leads Investment in MetaOptima to Accelerate FDA Approval and US Market Adoption of its AI-Powered Skin Diagnostics Platform
Nimbus Synergies led a $2.6 million investment in MetaOptima Technology, with additional funding from the WD Business Scale Up program, totaling over $4.6 million. The funds are earmarked to accelerate US FDA approval for DermEngine AI and expand its adoption in the US market.
2023-05
DermEngine Blog
DermEngine Receives Breakthrough Designation By FDA
MetaOptima received Breakthrough Device Designation from the US FDA for DermDx, an AI-powered tool within DermEngine designed to assist medical professionals in diagnosing potential skin cancer cases. This designation acknowledges the technology's potential to provide more effective treatment or diagnosis for life-threatening diseases.
2021-02
DermEngine Blog
MetaOptima's Peer-Reviewed Publications On Skin Lesion Classification Using AI
MetaOptima's Research & Development team has published peer-reviewed papers on skin lesion classification using AI, demonstrating the high accuracy of convolutional neural networks (CNNs) in assisting medical professionals with identification and diagnosis. Their AI algorithms achieved top positions in the 2018 ISIC challenge, with results published in The Lancet Oncology Journal.
2019-03

Frequently Asked Questions

MetaOptima offers DermEngine, an intelligent dermatology platform for imaging, documentation, AI-powered analysis, and workflow management. They also provide MoleScope, a smartphone dermatoscope for high-quality skin imaging, and OptimaScan, a total body photography station for 3D imaging and mole mapping.
MetaOptima's DermEngine utilizes image-based AI to assist dermatologists in identifying potential skin cancer cases like melanoma. The platform's AI image retrieval system displays similar pathology-labeled images and its algorithms support clinical decision-making, aiming to improve diagnostic accuracy.
MetaOptima's DermEngine supports comprehensive teledermatology services for both provider-to-provider and patient-to-provider consultations. The MoleScope app allows patients to capture and securely share high-quality skin images with their dermatologists for remote feedback and ongoing monitoring, enhancing accessibility to care.
MetaOptima provides simplified integration services for DermEngine with existing EMR/EHR and practice management systems to ensure a seamless workflow. This allows for automatic, real-time synchronization and transfer of patient data, enriching clinical records with intelligent dermatology analytics.
DermEngine is a secure, encrypted, cloud-based platform that is compliant with HIPAA and GDPR, ensuring robust data safety and patient privacy. The MoleScope app also adheres to HIPAA compliance for secure patient data management.
Founded in 2012, MetaOptima is a growing digital health company that has secured significant funding, including $8.6 million CAD in 2018 and $4.6 million in 2023 to advance FDA approval and US market adoption. They have established key partnerships with organizations like Sonic Healthcare and participate in initiatives such as the Digital Health & Discovery Platform.
MetaOptima aims to provide affordable and effective solutions, with DermEngine offering flexible pricing models including solo, group, and enterprise plans with various add-ons. Customer support is accessible through direct contact via phone and email, as well as an online knowledge base and a system for creating support tickets.

Related Companies

Pr
Precision Medical Ventures, Inc. Dba Revealdx
Seattle, WA, United States

Precision Medical Ventures, Inc. Dba Revealdx (RevealDx) is a Seattle-based healthcare AI company focused on dramatically improving lung cancer outcomes through non-invasive diagnosis. They develop advanced, radiomics and AI-enabled, lung cancer decision support software. Their flagship product, RevealAI-Lung, is a Computer-Assisted Diagnostic (CADx) software that analyzes patient lung computed tomography (CT) images to provide information […]
Sa
SafeBeat Rx
Saint Louis, MO, United States

SafeBeat Rx is a healthcare AI company focused on transforming cardiac care by expanding access to remote patient monitoring (RPM), continuous telemetry, event monitoring, and software-enabled remote therapeutic monitoring (RTM). The company’s core offering is an integrated technology that utilizes automated artificial intelligence-based software to analyze electrocardiogram (ECG) data. This technology is designed to replace […]
Me
Measure Labs, Inc. (Dba Preemptiveai, Inc.)
Seattle, WA, United States

Measure Labs, Inc., operating as PreemptiveAI, Inc., is a healthcare AI company focused on transforming healthcare from reactive disease management to proactive risk identification and prevention. The company has developed a “revolutionary” foundation model, a large-scale machine learning model, that interprets biomedical signals from smartphones and wearable devices to predict health outcomes in real-time. This […]
Ea
Earlitec Diagnostics dba EarliPoint Health
Plymouth, MN, United States

EarliPoint Health, formerly EarliTec Diagnostics, is a healthcare AI company dedicated to transforming autism care through innovative, FDA-cleared eye-tracking technology. The company’s core product, the EarliPoint System, is a medical device designed to aid qualified clinicians in the diagnosis and assessment of Autism Spectrum Disorder (ASD) in children aged 16 months through 95 months (7 […]
On
Onera B.V.
Eindhoven, Netherlands [1, 2, 6]

Onera B.V., operating as Onera Health, is a Dutch med-tech company that is transforming sleep diagnostics and monitoring with its innovative, self-applied, no-wire polysomnography (PSG) solution. [12, 19] Founded as a spin-off from the imec research center, a leader in nanoelectronics and digital technologies, Onera aims to make clinical-grade sleep studies broadly accessible, convenient, and […]
Di
Digestaid – Artificial Intelligence Development SA
Porto, Portugal

Digestaid – Artificial Intelligence Development SA is a healthcare AI company focused on developing advanced deep learning solutions for the detection of digestive lesions. The company aims to revolutionize gastrointestinal practice by applying AI technologies across digestive and pancreatobiliary tracts, as well as functional tests. Their solutions are designed to overcome diagnostic limitations of current […]
Suggest an Edit →
AI Tool Finder
AI-powered search. Results may not be comprehensive.